GEV vs KO: Which Is the Better Buy?

Side-by-side comparison of GE Vernova Inc. and The Coca-Cola Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-25.
GE Vernova Inc. Β· Industrials
$1,014.75
-16.2% upside to fair value
Med Conviction Grade C+
VS
The Coca-Cola Company Β· Consumer Defensive
$84.92
-10.2% upside to fair value
Grade C High Quality
QuantHub Verdict
KO has more upside to fair value (-10.2%). KO trades at a lower forward P/E (26.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GEV KO
Current Price $1,014.75 $84.92
Fair Value Estimate $850.00 $76.30
Upside to Fair Value -16.2% -10.2%
Market Cap $270.3B $365.4B
Forward P/E 34.3x 26.6x
EV / EBITDA 25.6x 20.7x
Price / Sales 6.6x 7.4x
Price / FCF 22.0x 29.1x
Revenue Growth YoY +15.0% +12.1%
Gross Margin 21.3% 61.7%
Operating Margin 5.9% 29.3%
Return on Equity 30.0% 43.6%
Dividend Yield 0.17% 0%
FCF Yield 4.5% 3.44%
Analyst Consensus Buy Strong Buy
Investment Thesis
GEV β€” GE Vernova Inc.
GE Vernova is the premier pure-play on the electricity side of the AI infrastructure supercycle. Its Power (heavy-duty gas turbines) and Electrification (grid equipment) segments are structurally supply-constrained, backed by a record $176B backlog that management says is 'mostly sold out through 2030.' The company raised FY2026 guidance for a second straight quarter to $45.5-46.5B revenue and $1…
KO β€” The Coca-Cola Company
The Coca-Cola Company is a leading global beverage company specializing in non-alcoholic drinks with a durable competitive moat driven by its strong brand and extensive distribution network. The business quality is high, evidenced by a 43.6% return on equity, robust gross margin of 61.7%, and solid revenue and earnings growth of 12.1% and 17.8% respectively in the most recent quarter. Despite the…
Accumulation Zones
Metric GEV KO
Zone Low $640.00 $57.22
Zone High $723.00 $64.85
In Buy Zone? No No
← GEV Research    KO Research β†’    All Research